Meet Dr. Nathan E. Nachlas

Nathan E. Nachlas, MD is the President of ENT and Allergy Associates of Florida and is the Medical Director of the Nose and Sinus Institute of Boca Raton. He is a pioneer in the field of minimally invasive procedures for the nose and sinuses and has served as a principal investigator for many clinical research studies in that field.

Dr. Nachlas received his undergraduate degree at Yale University, where he majored in molecular biophysics and biochemistry, and from where he graduated Phi Beta Kappa and Summa cum Laude. He attended medical school at the University of Chicago School of Medicine. He trained at Yale University (General Surgery) and Johns Hopkins University (Otolaryngology-Head and Neck Surgery). He then went on to complete a fellowship in Facial Plastic and Reconstructive Surgery in Beverly Hills, California prior to moving to Boca Raton, Florida in 1987. While at Johns Hopkins, he served as the Assistant Chief of Service for the Department of Otolaryngology-Head and Neck Surgery. He is Double Board-Certified in Otolaryngology-Head and Neck Surgery (ENT) and in  Facial Plastic and Reconstructive Surgery.

Minimally invasive sinus surgery was introduced into the United States at the Johns Hopkins Hospital in 1985. As the Assistant Chief of Service at that time, Dr. Nachlas had the honor of being one of the leaders of that conference. That launched him into a career of pioneering advances in this field. He performed the first outpatient computer-guided sinus surgery in 1992 and the first in-office computer-guided balloon sinuplasty in 2014. He has worked closely with industry to develop the techniques used throughout the country today. Dr. Nachlas remains at the forefront of innovation in the field of minimally invasive surgery of the nose and sinuses.

Recent Research Studies as Principal Investigator:

  • Safety and outcomes following hybrid balloon and balloon-only procedures using a
    multifunction, multi-sinus balloon dilation tool.

  • A Prospective, Multi-Center Registry of Subjects Treated with the ClariFix™ (Sponsor: Stryker Arrinex – CT-003 FROST Clarifix)

  • A Prospective, Multicenter Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction (AERWAY) (Sponsor: Aerin Medical AERWAY – TP900)

  • A Phase 2, Double-Blind, Placebo­Controlled, Parallel Group, Multiple Dose Study to Investigate Etokimab (ANB020} in Adult Subjects with Chronic Rhinosinusitis with Nasal Polyposis. (Sponsor: AnaptysBio Inc. “Eclipse”)

  • A Clinical Evaluation of Propel Mini Sinus Implant Placement in the Frontal Sinus Ostia Following In-Office Dilation. (Sponsor: Intersect ENT)

  • THN3: Targeted Hypoglossal Neurostimulation Study. (Sponsor: LivaNova, PLC ImThera Medical, Inc.)

  • A RandomizEd CLinicaL Study of Safety and EffIcacy for the Eustachian Tube Balloon CaTheter (ELLIOTT). (Sponsor: Acclarent, Inc.)

  • Safety and Preliminary Efficacy of Dexpramalpexole In Patients with Chronic Sinusitis with Nasal Polyps and Eoslnophillia. (Sponsor: Knopp Biosciences, LLC.)

  • A Phase III investigation of topical application of Cocaine HCl 4% solution on safety and efficacy and Cocaine HCI 4% and 10% solution on safety in local (topical) anesthesia for diagnostic procedures and surgeries on or through accessible mucous membranes of the nasal cavities. (Sponsor: Lannett Co. Inc.)

  • Phase III Randomized, Multicenter, Double-Blind, Placebo-Controlled Clinical Trial of Omalizumab in Patients with Chronic Rhinosinusitis with Nasal Polyps. (Sponsor: Hoffmann-La Roche Ltd “PPD”)

  • Spirox Latera™ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OR) Study. (Sponsor: Spirox)

  • Spirox Latera TM Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OFFICE) Study. (Sponsor: Spirox)


Facebook icon          Instagram icon